Clinical trial
EF5 in Treating Patients With Solid Tumors
NCT00003282 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003282 |
|---|---|
| Title | EF5 in Treating Patients With Solid Tumors |
| Official title | Phase I Trial of EF5, an Agent for the Detection of Hypoxia |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other, Procedure |
| Interventions | EF5, therapeutic conventional surgery, biopsy, pharmacological study |
| Enrollment | 50 |
| Start date | Mar 1, 1998 |
| Primary completion | May 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: